These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6965106)

  • 1. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7.
    Harmon JM; Thompson EB
    Mol Cell Biol; 1981 Jun; 1(6):512-21. PubMed ID: 6965106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased acquisition of glucocorticoid resistance in tetraploid human lymphoid cells.
    Gledhill RM; Gray DA; Solberg-Scott M; Norman MR
    Mol Cell Endocrinol; 1983 Jan; 29(1):67-77. PubMed ID: 6572161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementation between glucocorticoid receptor and lymphocytolysis in somatic cell hybrids of two glucocorticoid-resistant human leukemic clonal cell lines.
    Yuh YS; Thompson EB
    Somat Cell Mol Genet; 1987 Jan; 13(1):33-45. PubMed ID: 3468632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-glucocorticoid receptor-mediated effects of the potent glucocorticoid deacylcortivazol.
    Harmon JM; Schmidt TJ; Thompson EB
    Cancer Res; 1982 Jun; 42(6):2110-4. PubMed ID: 6951631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucorticoid resistance in murine lymphoma and thymoma lines.
    Bourgeois S; Newby RF; Huet M
    Cancer Res; 1978 Nov; 38(11 Pt 2):4279-84. PubMed ID: 698966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glucocorticoid responsiveness of CD4+ T-cell clonal lines grown in serum-free media.
    Chilton DG; Johnson BH; Danel-Moore L; Kawa S; Thompson EB
    In Vitro Cell Dev Biol; 1990 Jun; 26(6):561-70. PubMed ID: 1972702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
    Zawydiwski R; Harmon JM; Thompson EB
    Cancer Res; 1983 Aug; 43(8):3865-73. PubMed ID: 6134583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines.
    Adebodun F; Post JF
    J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of glucocorticoid-resistant human leukemic cells by somatic cell hybridization.
    Harmon JM; Thompson EB; Baione KA
    Cancer Res; 1985 Apr; 45(4):1587-93. PubMed ID: 2858265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molybdate-sensitive and molybdate-resistant activation-labile glucocorticoid-receptor mutants of the human lymphoid cell line CEM-C7.
    Harmon JM; Schmidt TJ; Thompson EB
    J Steroid Biochem; 1984 Sep; 21(3):227-36. PubMed ID: 6492789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptors in human leukemias and related diseases.
    Thompson EB; Smith JR; Bourgeois S; Harmon JM
    Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
    Ashraf J; Kunapuli S; Chilton D; Thompson EB
    J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.
    Thompson EB; Johnson BH
    Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a glucocorticoid-sensitive human lymphoid cell line.
    Norman MR; Thompson EB
    Cancer Res; 1977 Oct; 37(10):3785-91. PubMed ID: 269011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J; Thompson EB
    Mol Endocrinol; 1993 May; 7(5):631-42. PubMed ID: 8316249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
    Gu L; Zhang G; Zhang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
    Powers JH; Hillmann AG; Tang DC; Harmon JM
    Cancer Res; 1993 Sep; 53(17):4059-65. PubMed ID: 8358735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.